Clinical Trial Update: Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing tipranavir/ritonavir versus saquinavir/ritonavir with two NRTIs in protease inhibitor-experienced HIV-1 patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ritonavir (Ritonavir)
• Saquinavir (saquinavir)
• Tipranavir (tipranavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 2 | Status: TERMINATED